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A b s t r a c t : The history of development of the Genetic Engineering Technology 
has been brought out with a brief description of the current status of some of the 
techniques used in gene cloning. The achievements and potential applica­
tions of the technology in medical sciences and its possible impact on the 
Society in future have been discussed, as far as possible, in a semitechnical 
language.
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I . Introduction
This article is addressed basically to intelligent laymen belonging to physical, 
biological and medical sciences. All attempts have been made to present facts and 
figures in a semitechnical language. The article presents the New Technology 
through four different facets ; (i) introduction of the technology by bringing out 
findings and discoveries which led to its emergence, (ii) brief description of 
the essential methods that are used in the practice of the technology, (iii) potential 
applications of this technology and achievements made in the field of medical 
sciences with particular reference to the emergence of new pharmaceutical industries 
and (iv) brief analysis of the wider applications and implications of this 
technology to the human race of the days to come.
In the living world, Man has the distinct advantage of being endowed with 
the noble virtue of the power of thinking and accordingly he is being constantly 
goaded by the eternal thirst for knowing the unknown and seeing the unseen. And 
to his amazement and wonder he finds that he himself, his origin and action, is a 
mystery of mysteries. He has thus been puzzled through ages, through generations, 
in understanding himself. Great philosophers have exposed their learned views 
on clarifying what life is and how it originated. It has been expressed that life is 
something supernatural, something which goes beyond explanation, something 
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which is created by someone who is omnipotent, omniscient and omnipresent. 
But all along some other philosophers have been constantly refusing to accept this 
obscurantism as a solution and have been trying to formulate the basic concepts of 
life in terms of the principles and theories of the natural sciences. They argue that 
all forms of life have so far been found to consist of the same atoms or elements 
which in some way or other constitute the various inanimate objects. But the 
molecules which form by the combination of atoms might have some differentiating 
features. The simplest manifestation of life has been found in the viruses, the 
very small organisms whose dimensions might be as small as 100 Angstrom 
(10~“ cm). The viruses are unique in the sense that they share the properties of 
both the living and non-living entities. They are living in the sense that they can 
reproduce themselves in the exact sense. They are non-living in the sense that 
they can be crystallised and beautiful crystals of different viruses have been 
extensively used for understanding their structural organisations. Surely we have 
no experience of crystalline dogs so far and I shudder even to think of crystalline 
human beings ! Many of the simpler viruses have been found to consist of only 
two different types of chemical molecules, viz., the proteins and the nucleic acids 
and these are present in all forms of life known so far. It thus appears that these 
two chemicals are the minimum requirements for the manifestation of life. One 
may now ask as to whether the secrets of life lie in
(i) the peculiar association of both the chemical molecules, protein and 
nucleic acid ;
(ii) one of them is of primary character and dictates the process of life ;
(Mi) none of them is at all necessary and essential for the manifestation of 
life. The key to the secret of life probably lies in some still unknown 
physico-chemical agent;
or, (iv) the mysteries of life are beyond the scope of the natural sciences.
The unequivocal answer to these questions has yet to be obtained. However, 
the achievements and progress of the science of molecular biology (which originated 
only some 30 years ago) have already been so spectacular as to rouse the natural 
enthusiasm and hope that life may be exactly known in terms of the physico­
chemical forces in the days ahead. It has by now been apparent that protein is 
rather the food stuff of life, the message of which is actually coded in the structure 
of the nucleic acid molecules.
or,
or.
2. D N A , genes and diseases
The nucleic acid is mainly of two types, the deoxyribonucleic acid or D N A and 
ribonucleic acid or RNA. D N A is mostly of primary character. A  nucleic acid 
molecule contains a linear array of four different simpler molecules known as 
nucleotides and the sequence in the arrangement of these nucleotides in the nucleic 
acid molecule of any species is supposed to decide its overall genetic and functional 
potential (Figure 1). This sequence of nucleotides determines the type or types 
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of protein molecules the particular species will or can produce and so on. Informa­
tion in living systems is thus supposed to flow in general from DNA to RNA and 
then to protein molecules.
DNA R N A P R O T E I N
V.____ J
Information normally flows unidirectionally, from DNA to RNA and then to 
Protein. Only in cases of some specific RNA viruses, the information initially flows
Figure I. Chemical structure of a double stranded DNA chain. The two strands 
are each made of a deoxyribose sugar molecule (DR) and a phosphate group ( ■ )  
alternately joined to each other by covalent bonds. The DNA chain hero jShows 
an arbitrary sequence of the four bases, adenine (A), guanine (G), cytosine (C) 
and thymine (T) along its length. The complementary nature of base pairing, 
i.e., adenine with thymine (by two hydrogen bonds) and guanine with cytosine 
(by three hydrogen bonds) and vice-versa should be noted. A nucleotide mole­
cule comprising one sugar molecule, one phosphate group and one of the four
bases (A, T, G or C) forms an elementary or monomeric unit of the polymeric 
DNA molecule.
in the reverse direction, from RNA to DNA, and then as usual to RNA and 
Protein. Elucidation of the structure of different DNA molecules and in particular 
of the sequence of arrangement of the four different nucleotides along their chains 
thus form a very important area of investigation in molecular biology. A  simple 
mathematical analysis can give us an idea of the information content in a DNA 
molecule, assuming that the information content is coded in the sequence of 
basss along tho chain. If a DNA chain length is snch as to contain only f i «  
nucleotides then the number of ways in which these five nucleotides can be 
arranged along the DNA chain length is simply =  1024 assuming that th e re t 
endless supply of each of the four nucleotides (A  ^  G = or C n and th.t U  
no restriction in the repetition of any nucleotide along Ihe DNA l e n l  T r h '  
DNA ntolKule is so long as to contain 10" nucleotides along its length (as in 
huntan DNA), then the number of ways these four n u c le o t L  canT a r r a r i e d
along DNA length is 4 - .  i.e„ an extremely large number. For s u c h T Z a  
molecule, the information content may thus ho i/ariari k i ^
large number of possibilities. This is a simple but crude exol'' f  '"f'h'tblV
of infinite number of yariations in the n C w ^ d  T r  ” "  
of a DNA molecule having a specific base sequence'end "a S iJ ^ c H r ilZ r ,:
A* adenylic acid ; T*-thymidylic acid ; G*-guanylic acid ; C *- cytidylic acid.
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content. The size of the entire D N A molecule (genome D N A ) of an organism 
varies in accordance with the nature and size of the organism. Similarly, the size 
of a gene also varies in accordance with the nature of the gene (Table 1). Also
Table 1. A comparative picture of the sizes of some genomic DNAs and genes.
Genome DNA Size*(no. of bases) Genes
Size*
(no. of bases)
Virus
5x10 * transfer RNA 75-90
A wild type 46.5x10* Xenopus laevis 5S>RNA 120
Simian Virus SV40 5.3 A 10* Sea Urchin histone gene 6.54x10*
Bacterium
E s c h e r i c h ia  c o l i 4.0 <1 O' Ovalbumin natural gene 7x10 *
Commonly used plas­
mid vehicle
3-30 <10^‘ Coding sequence 1859
Human 10**
♦ For double stranded DNA, size is in no. of base pairs.
genes in the cells of more complex organisms are different in structure from the 
genes in bacteria. In such cells, the coding region of a gene is broken up along the 
DNA strand. Determination of base sequence in a DNA molecule is thus an 
important proposition and the men who devised methods for sequence determination 
were aptly rewarded with Nobel Prize. In fact, the development of rapid DNA 
sequencing techniques by the mid '70s contributed the final element required to 
make an entire recombinant D N A technology. In patients suffering from sickle­
cell anaemia, the amino acid valine replaces glutamic acid in the chain of the vital 
blood protein, haemoglobin. The root of this defect could be traced to the 
alteration of a single nucleotide in corresponding D N A chain, i.e. thymidylic acid 
replaced by adenylic acid.
Segment of the j8-Chain of haemoglobin and its gene
Normal adult
D N A ... T G T G G G TA C TA C T T T  ...
RNA ... A C A CCC A U G A U G A A A  ...
HbA ... Thr - Pro -  Glu -  Glu -  Lys ...
D N A ... T G T G G G A A C
f
T A C T T T  ...
RNA ... A C A CCC U U G A U G A A A  ...
HbS ... Thr - Pro -  Val -  Glu -  Lys ... 1Patient with sickle­
cell anaemia
Haemoglobin contains tw o  'alpha' and tw o  'beta' chains. Each 'alpha' chain 
contains 141 amino acids and each 'beta' chain 146 amino acids. In sickle-cell
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anaemia patients, the beta chain is defective, the glutamic acid in position six of 
the peptide chain being replaced by valine. This defect could be traced to a defect 
in DNA nucleotide sequence in the haemoglobin gene for ^-chain. The importance 
of the sequence of nucleotide can thus be appreciated. We are naturally not 
satisfied with this knowledge of the basis of the disease sickle-cell anaemia, we 
would obviously like to devise methods so that we can alter this defective sequence 
and set it right to cure the disease. We are getting involved in devising techniques 
for altering the sequence of nucleotides in DNAs of living species either by deletion 
or addition of an extra piece of a short D N A chain. This ushers in the new 
discipline of science, commonly known as genetic engineering, which basically 
involves DNA technology. Major advances achieved recently in the field of D N A  
technology have not only endowed credibility to it but also established the science 
of genetic engineering as one of the most prospective technologies born in the 
present days.
3. Genetic engineering : basic aspects
Much of the early works in the field of genetic engineering involve the manipulation 
of the genetic structure of a bacterium, Escherichia coli which is commonly found 
in our digestive tract and which can be easily grown in the laboratory (Cohen, 
1975). These bacteria usually contain two types of D N A molecules within their 
cell, of which one is very large in size and is usually known as its chromosome or 
genome. The other type consists of one or more much smaller D N A molecules 
which the bacteria can shed off or acquire under various environmental conditions, 
can be propagated in alternative states, either autonomously in the cytoplasm or as 
an integral part of the bacterial chromosome and are generally known as plasmids. 
Sometimes a plasmid can pick up a short segment of DNA from the chromosome of 
its own cell and transfer it to the cell of a related bacterial species, and sometimes 
the plasmid and the segment of chromosomal DNA can become integrated into the 
chromosome of the recipient cell. By suitable microbiological and chemical 
processes, these plasmids can be removed from the bacteria, cut open at a specific 
site in the laboratory (since normally they do not provide any free end, i.e. they 
form closed circles), joined at one end to a new piece of gene bearing the required 
information (say, the information to produce any particular protein), resealed to form 
a bigger circle and then reinserted in the same bacterial cell. This bacterium 
can then be grown again in the laboratory and induced at will to synthesize the 
particular protein the information for which was thus inserted into its plasmid. 
Stanley N. Cohen and associates were thus able to insert into £. coli some genes 
of the toad Xenopus laevis. The composite plasmid D N A thus formed was termed 
DNA chimera in analogy with mythological chimera (e.g., a creature with the head 
of a lion, the body of a goat and the tail of a serpent).
4* Early breakthroughs
These achievements were made possible by a series of independent discoveries 
made in rapid succession in the late 1960's and early 1970's and included at least
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several distinct elements : (i) the discovery of means for the cleavage of DNA at 
highly specific sites, (ii) the development of simple and generally applicable
methods for the joining of DNA moiecules, (iii) the discovery of a suitable gene
Table 2. Some selected restriction enzymes generating butt and cohesive ends
with the specific nucleotide sequences they recognize and the organisms from
which they are purified (origin).
Enzyme Origin
Nature 
of Ends 
generated
Recognition 
sequence and 
cleavage site
Alu 1 Arthrobacter luteus Butt
'Ir
5 -^AGCT 3 ' 
3 -^TCGA-5 '
Bal 1 Brevibacterium albidum Butt 5^  - T G G C C A -3 '
3 ' - ACCGGT-^5'
f 1
5 '- G T  py pu A C - 3 ' 
3 '-  CA pu py TG - 5 '
Mine II Haemophilus influenzae Rc Butt
Bam HI Bacillus amyloliquifaciens Cohesive 5 ' GGATCC 3 
3 '- C C T A G G -5
1 t
5 ' - GAATTC- 3 ' 
3 '-C T T A A G  5 '
Eco Rl Escherichia coli RY 13 Cohesive
Hind III Haemophilus influenzae Rd Cohesive
4' 'f
5 ' - AAGCTT 3' 
3 '-T T C G A A -5 '
t  4
5 ' C T G C A G -3 ' 
3 '-G A C G T C  - 5
Pst 1 Providencia stuartii 164 Cohesive
carrier that can replicate both itself and a foreign DNA segment linked to it.
(iv) the devising of means of introducing the composite DNA molecule into a
Figure 2, The restriction endonuclease Eco Rl has the property of cleavinp com­
plementary strands of DNA at sites (shown by arrows) four nucleotides apart 
and recognises the base sequence GAATTC. Such cleavage yields DNA fragments 
with complementary overlapping single-stranded ends. A s a result, the end 
of any DNA fragment produced by Eco Rl cleavage can anneal with any other 
fragment produced by the same enzyme.
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functional bacterial cell etc. These ingenuous biochamical and biological mani­
pulations were made easier by the discovery of a group of enzymes called 
restriction endonucleases (Roberts 1980) which could cleave D N A at specific 
sites producing either complementary ended fragments or fragments with flush or 
butt ends (Table 2). The specific endonuclease, Eco R1 has the property of cleaving 
complementary strands of DNA at sites four nucleotides apart (Figure 2). Such 
cleavage yields DNA fragments with complementary overlapping single-stranded 
ends. As a result the end of any DNA fragment produced by Eco Rl cleavage can 
anneal with any other fragment produced by the enzyme. The 1978 Nobel Prize 
in Medicine was aptly awarded to the discoverers of these enzymes.
5. Gene cloning : essential steps
Some of the essential steps involved in the DNA cloning (Sinsheimer 1977, Glover 
1980, Perbal 1984) procedure are (i) choice of cloning organism, (ii) choice of 
cloning vehicle (vehicle DNA), (iii) isolation of DNA to be cloned (Foreign D N A ),
(iv) integration of foreign DNA into vehicle DNA (production of D N A  chimera),
(v) insertion of DNA chimera into cloning organism and (vi) selection of cloned 
DNA (Figure 3). For each of these steps, various alternative procedures are 
available and the selection of any depends on the nature of the problem to be 
tackled. The ideal cloning organism is one which can be easily grown, which 
lacks the restriction enzymes (so that the cloned D N A  is not chopped), which is 
preferably recombination deficient (rec A “) etc. The Escherichia coli bacteria 
have been widely used for such purposes for many such obvious reasons. As for 
the cloning vehicle is concerned, it should be self replicating, should be amenable 
to easy manipulation (isolation, transfer etc.), should have the property that helps 
in the selection of cloned DNA (antibiotic resistance factors etc.), should help 
in the production of multiple copies of cloned D N A (gene amplification) and should 
be easily amenable to cleavage by restriction enzymes and splicing with foreign 
DNA. Some of the commonly used vectors are plasmids, D N A of the bacteriophage 
A or the DNA of the virus SV-40. As for the isolation of foreign D N A (or gene) or 
the DNA (or gene) to be cloned, methods vary with the nature of the problem. In 
some cases it so happens that the isolation of a specific gene or D N A is a very 
difficult task but the isolation of the corresponding messenger RNA (m -R N A ) in a 
pure form is relatively much easier. In such cases, the foreign D N A is synthesized 
from the m-RNA by enzymatic means (Figure 4). Such D N A is termed compli­
mentary DNA or C -D N A . In some other cases it may so happen that a particular 
gene or DNA can be synthesized by chemical methods and such D N A  is termed 
synthetic DNA. An example of such a synthetic D N A is the gene for tyrosine 
specific transfer RNA synthesized by Khorana. The integration of foreign D N A  
into vehicle DNA involves a number of steps ; (i) cleavage of both the foreign and 
vehicle DNA by appropriate restriction enzymes and (ii) mixing and annealing of 
the cleaved vehicle and foreign DNA fragments. In some cases, the cleaved D N A  
fragments of both kinds (vehicle and foreign) are treated with enzymes such as
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terminal deoxynucleotidyl transferase (TD N T), to add homopolymer tails of deoxy- 
nucleotides to each DNA fragment in such a way that annealing is much facilitated 
(Figure 5). In such cases, single stranded regions appear in the annealed DNA 
chimera and such single stranded gaps are to be repaired by treatment with the
ESSENT IAL  STE PS  IN DNA/GENE CLONINS
Figure 3. A schematic presentation of the essential steps involved in the cloning 
of a piece of DNA or gene using a bacterial cell. The human insulin gene vvas 
similarly inserted into the bacteria, Escherichia coli.
enzyme exonuclease III and finally (iii) the annealed DNA is sealed by treatment with 
DNA ligase. The reconstructed plasmid or plasmid chimera thus produced needed 
to be reintroduced in a bacterial cell by a process called transformation and allowed 
to be expressed. As stated earlier, Escherichia coli is often the organism of choice 
for cloning. For reinsertion of the plasmid chimera, the bacterial cell had to be 
treated with calcium chloride solution of appropriate molarity at O X  and then
2 0 S N Chatterjee
subjected to a heat shock by suddenly raising the temperature of the mixture. This 
treatment usually makes the bacterial cell permeable to foreign DNA and the 
plasmid chimera could thus be reinserted. As illustrated in Figure 3, different 
types of plasmid chimera can be formed during the annealing of the mixture of 
foreign and vehicle DNA components and as such different plasmid chimeras could
5 P
P O L Y A - m R N A
- A A A A A A - - -A A 3 0H
+ Oligo dT
5 P -AAAAAA- -*AA 
T T T T
REVERSE
TRANSCRIPTASE
5 P .AAAAAA* *.AA
3 'O H -
C DNA SYNTHESIS
DEGRADlATION OF mRNA 
(ALKALI OR RNASE H)
■ TTTTTT5 P
+ DNA POLYMERASE I
-T TT T T T 5 P
SELF ANNEALING WITH 3^0H ^
TERMINI LEADS TO LCX)P FORMATION
SI NUCLEASE 
TO DEGRADE LOOP
3'0H- 
5 P -
5 P 
3'OH
DOUBLE STRANDED DNA COPYOFmRNA
Figure 4. Schematic illustration of the steps involved in th» e .u • .
plementary DNA (C-DNA) from the messenger RNA fm RNAT
pre‘re n o e o fS e r’and"d?ox^'n^cleosid;f- h '°"f* '° " ^‘^ "d T n 'th e
has-been used ,o degrade the single strande^d “o ^ M ^ o ro ^ m 'ih ^ 'J o T m '^ ra to S
b a c " e 7 a r c d l h  d ' '
containing the particular gene to be cloned ^ plasmid chimera
methods of selection are l i l a J 'e .  Some o l ^ h ^
feat,on of genes, by physical and/or microbiol^gicar
While others do tha selection after cloning, m onrsu^h Z h  .  ' tf
Plasmid rWL7, is cleaved by the restriction en Jn !e
enzyme Pst J thereby inactivating the
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ampicillin resistance factor normally present in the plasmid. The foreign DNA Is 
then inserted at the cleavage site of the plasmid and the recombinant DNA plasmid 
is allowed to transform the bacterium E. coli. These bacteria are then cultured In 
media containing ampicillin and D-cycloserine besides the nutrients. Because of 
the presence of ampicillin in the growth medium, all growing bacteria except the
p » t i
PASSENGER DNA
OtOESTONl P*t I 
W I T H  ♦
♦
----- CTGCA; G —
-G; A CGTC-
t
T E R M I N A L
TRANSFERASt -i-dGTP
GGGGACGTC
"CTGCAGGGGG- 
“C5 .
-GG
TERMINAL
TRANSFERASE
+ dCTP
CC -CCC 3' .
CCCC
ANNEALING
5C -
GGGGACGTC-
. C TGCAGGGGGGGGGGGG 5 - 
'  G , CCCCCCCCC 3'-
CCCC
------------CTGCAlG
^ g!^ .c g tc
G GGGGG- 
C C C C C C ■
TRANSFORMATION
i
Psti  SITE
T
CCCCCCTGCAG-
•6GGGGGACGTC
VECTOR
PASSENGER
Figure 5. Illustration of the use of homopolymer tails of deoxynucleotides for 
cloning purpose. Here the foreign D N A  with dC tails has been cloned into a 
vector D N A  whose cloning site has been elongated with dC  tails. In this method 
the cloned foreign D N A  can be recovered because the Pst I recognition sites are 
regenerated after ligation.
actual transformants (those containing the foreign DNA inserted in the plasmid 
chimera by inactivating the ampicillin resistance factor) will be killed. Thus the 
actual transformants can be enriched and selected. The transformed cell, when it 
divides, will copy the hybrid DNA and pass it on to its daughter cells. If the new 
gene in the hybrid DN A is expressed, each of the daughter cells will make the new 
protein encoded for in the DNA.
6. Medical applications
Following similar procedures, a spectacular break-through in genetic engineering 
has been achieved very recently by the joint collaboration of the City of Hope 
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Medical Centre in California and the San Francisco firm, Genentech (Gilbert and 
Taunton-Rigby 1984). The achievement Was the production of human insulin by 
the bacterium, Escherichio coli. Insulin is a protein based hormone normally 
produced in our pancreas. Diabetic patients need supply of insulin from outside 
sources, mostly from the pancreas of slaughtered cattle and pigs. It takes the insulin 
content of tw o c o n s  to satisfy the needs of a diabetic for one year. If one takes 
account of the gradually increasing number of the diabetics in the w orld  and also of 
the fact that their lives arc now being prolonged by virtue of their grow ing aware­
ness and better medical attention they receive, one can immediately appreciate the 
need for developing alternative source of insulin production. In this respect, 
genetically engineered bacteria can provide an unending source of insulin. The 
achievements of the City of Hope research team include the chemical synthesis of 
the human insulin gene in the laboratory test tube. Cattle insulin or pig insulin 
differs from human in several amino acids, and therefore may produce and does in 
fact produce allergic and untoward immunological reactions in many diabetic 
patients. The human insulin manufactured in bacteria w ill eliminate this drawback. 
In 1977, the same research team succeeded in synthesizing the human gene which 
produces the brain hormone, somatostatin. The next important step was to insert 
the insulin gene next to a cluster of bacterial genes called the "lac operon". The 
"lac operon" can be imagined as a "kind of switch system" w hich can 
regulate the production of protein in the bacterium. The production of insulin 
can then be turned on by adding certain chemicals in the bacterial grow th 
medium.
The new technology promises to have unlimited applications in medical science 
(Gilbert and Taunton-Rigby 1984). The recombinant D N A  technology can be 
used to produce commerical quantities of human enzymes and hormones. Production 
of insulin in bacteria, as elaborated earlier, is one of the early spectacular achieve­
ments of this technology. More than one hundred new biotechnology companies, 
e.g., (i) Cetus Corporation, Emeryville, California, (ii) Genentech Inc., San Fran­
cisco, (iii) Biogen, Geneva etc., have started functioning in this area. The w ay 
is now open for the manufacture of virtually any hormone, vaccine, antibodies etc. 
which has a protein base. Some of the first products that are emerging are human 
insulin, alpha interferon, gamma interferon, human and animal grow th hormones, 
vaccines for foot-and-mouth disease virus and for hepatitis B etc. Plasminogen 
activators are forthcoming. These proteins can dissolve blond clots and therefore 
may be used to treat heart disease. Manufacture of these human products by this 
technology have additional advantage. Compounds extracted from animal or 
plant tissues exhibit a diverse range of adverse effects. Many plant products are 
effective but addictive, such as codeine. Animal proteins are frequently inactive 
in man or not well tolerated and cause immunological responses. Eventually w e can 
expect to have available every active human protein in amounts sufficient for full 
clinical trials and at prices low enough for widespread medical use.
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In the not too distant future, gene splicing technology is likely to 
engender a thorough understanding of how cells work on the molecular level. 
Precise knowledge w ill evolve on the differentiation of cells, on the signals that 
specify, dictate or modify growth, on how  a normal cell is transformed into a 
malignant one etc. The knowledge could certainly be used to renew a kidney or a 
cirrhosed liver, to revert back a malignant cell to a normal one, to change fat 
deposits etc. W ith these achievements, the practice of medicine in the days to 
come w ill undergo a dramatic change. N ow  we treat illness after they occur, 
tomorrow w e w ill focus on detection before symptoms appear, on testing for 
disease susceptibility, on prevention of diseases etc. Further, the ability to 
recombine D N A  w ill lead to new and better diagnostic methods for detecting 
infectious agents and inherited diseases. It is no longer a fiction that someday the 
entire genetic code of each human being w ill be deciphered and our lives w ill 
undergo a total transformation. Besides application in medical science, the new 
technology has tremendous iwtent'al in bringing beneficial changes in diverse 
aspects of human civilization including environmental pollution, energy and food 
production.
7. Possible misuse of this technology
Any new scientific achievement may have both the potentially beneficial and also 
harmful possibilities and genetic engineering is no exception to this. The potential 
dangers were imagined to arise mostly from uncontrolled, rather ill-controlled, or 
motivated use of the techniques. Of particular concern is the fact that this new 
technology, w hich permits combination of genetic information from very different 
organisms, places us in an area of biology w ith many unknowns. These researches 
may thus lead to w orldw ide epidemics caused by newly created pathogenic bacteria 
let loose in the environment, the triggering off of catastrophic ecological imbalances, 
neyv tools for militarists and terrorists etc. Such hypothetical risks however could 
not be brushed aside lightly and a Committee on Recombinant D N A  Molecules was 
established in 1973 in U S A  to consider imposition of restrictions on researches 
in genetic engineering. The Asilom ar Conference held in 1975 at the Pacific 
Grove in California put forward a new concept of biological containment and 
certain guidelines in genetic engineering experiment. The matter grow into such a 
degree of seriousness that the City Council of Cambridge, Massachusetts imposed 
a six month ban on genetic engineering research at tw o  leading institutes in U S A , 
the Harvard University and tha Massachusetts Institute of Technology. The 
situation however improved considerably in the subsequent days, thanks to the 
acquirement of increasing scientific confidence that the research is not as dangerous 
as some of its critics had suggested. Also, the actual laboratory use of the 
techniques of Recombinant D N A  have largely dissipated the visions of new forms 
of life created by tha insertion of fresh foreign D N A . The Recombinant D N A  
research thus received a new boost on January 2, 1979 when the guidelines and 
restrictions were relaxed significantly in the United States.
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8. Possible impact on society
If we do not lose faith in mankind and can forget or take care of the possible ill-use 
or motivated use of the results of genetic engineering and related technologies, 
we can reasonably imagine of the days ahead when we shall have at our disposal 
methods of modifying our physical and mental constitution, of correcting errors 
of nature, of eliminating hereditary faults etc. leading to the evolution of a so- 
called superhuman race. But man does not live with science alone, he lives in 
societies and is guided by social and ethical values. Will there by any serious 
conflict between the scientific achievements and the social and ethical values of 
the human race ? Our social and ethical values will probably undergo a sea-change 
by then. Will science devour the human civilization? Only Future can answer 
this. But for the time, let us recall the humorous forecast made by Jean Rostand 
while depicting the anguish of a 'Future Man', modified and sophisticated by 
varied and repeated treatments, most of which are still- and this must be 
emphasized imaginary : "I was born of stock chosen and irradiated by neutrons ; 
they chose my sex and I was born of a mother who was not mine ; during my 
development, I have been given injections of hormones and D N A ; I have benefited 
from treatment which superactivated the cortex of my brain ; after my birth, tissue 
grafts were made to improve my intellectual development and even now I submit 
myself every year to a course of maintenance treatment in order to keep my mind 
in good shape and my instincts at an optimum level. 1 have no reason to be 
discontented with my body, my sex, or my life, but who am I ? "
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